DA

Deepika Ahuja

Active Director Director DIN 11483621
DIN 11483621 First appointment Jan 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Deepika Ahuja

Data last updated:

Deepika Ahuja is a Director at Innottaas Innovations Private Limited (since 2026). The company operates in Pharma.

DIN 11483621
Primary Designation Director
Industry Pharma
First Appointment 14 Jan 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20262026Active

Board colleagues of Deepika Ahuja

Directorship timeline

Open interactive timeline →
Innottaas Innovations Private Limited
Premium access

Shareholding and investment profile for Deepika Ahuja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepika Ahuja

Deepika Ahuja currently holds 1 directorship: Innottaas Innovations Private Limited (Director, since 14 Jan 2026).

Deepika Ahuja was first appointed on 14 Jan 2026 as Director at Innottaas Innovations Private Limited.

The current boards of Deepika Ahuja's companies include Mukul Sain Jain (Innottaas Innovations Private Limited), Parikshit Chopra (Innottaas Innovations Private Limited), Shobha Jain (Innottaas Innovations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available